AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 39466243 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 3695
Study 39466245 — intervention group
Group type: EXPERIMENTAL
Intervention: Large Language Model (LLM)
Number of subjects: 50
Study 39466245 — intervention group
Group type: COMPARATOR
Intervention: Conventional resources only
Number of subjects: 50
Study 39466245 — intervention group
Group type: EXPERIMENTAL
Intervention: Large Language Model (LLM) alone
Number of subjects: 50
Study 39466253 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide Therapy
Number of subjects: 0
Study 39466327 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-immersive virtual reality game-based training (nIVRGT) plus conventional physiotherapy (40 min + 20 min)
Number of subjects: 25
Study 39466327 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy and rehabilitation program (60 min, 3 days a week for 6 weeks)
Number of subjects: 25
Study 39466427 — intervention group
Group type: EXPERIMENTAL
Intervention: Hugo™ Robotic-Assisted Surgery System
Number of subjects: 20
Study 39466542 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning (DL)-based reconstruction
Number of subjects: 50
Study 39466542 — intervention group
Group type: COMPARATOR
Intervention: Conventional reconstruction
Number of subjects: 50
Study 39466584 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmenting adaptations
Number of subjects: 70
Study 39466584 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing/Reordering adaptations
Number of subjects: 70
Study 39466584 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-reported adaptations
Number of subjects: 70
Study 39466640 — intervention group
Group type: EXPERIMENTAL
Intervention: Early valve intervention (transcatheter or surgical aortic valve replacement)
Number of subjects: 224
Study 39466640 — intervention group
Group type: COMPARATOR
Intervention: Guideline-directed conservative management
Number of subjects: 224
Study 39466640 — intervention group
Group type: EXPERIMENTAL
Intervention: Early valve intervention
Number of subjects: 224
Study 39466816 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (single dose)
Number of subjects: 1000
Study 39466816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 39466830 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-DP (KK2.0)
Number of subjects: 0
Study 39466830 — intervention group
Group type: COMPARATOR
Intervention: Manual screening of KK stool thick smears (KK1.0)
Number of subjects: 0
Study 39466903 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 901
Study 39466903 — intervention group
Group type: COMPARATOR
Intervention: Clinical Surveillance
Number of subjects: 901
Study 39466933 — intervention group
Group type: EXPERIMENTAL
Intervention: KSL-W chewing gum (30 mg dose)
Number of subjects: 0
Study 39466933 — intervention group
Group type: EXPERIMENTAL
Intervention: KSL-W chewing gum (doses ≥ 20 mg)
Number of subjects: 0
Study 39466933 — intervention group
Group type: COMPARATOR
Intervention: Placebo chewing gum
Number of subjects: 0
Study 39466933 — intervention group
Group type: EXPERIMENTAL
Intervention: KSL-W chewing gum (2-100 mg single doses)
Number of subjects: 0
Study 39466933 — intervention group
Group type: EXPERIMENTAL
Intervention: KSL-W chewing gum (4-75 mg multiple doses)
Number of subjects: 0
Study 39467244 — intervention group
Group type: EXPERIMENTAL
Intervention: goflkicept therapy
Number of subjects: 16
Study 39467285 — intervention group
Group type: EXPERIMENTAL
Intervention: Early in-bed cycle ergometry
Number of subjects: 360
Study 39467285 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in the abstract)
Number of subjects: 360
Study 39467288 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-based social skills training
Number of subjects: 90
Study 39467288 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional social skills training
Number of subjects: 90
Study 39467288 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 90
Study 39467538 — intervention group
Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 44
Study 39467550 — intervention group
Group type: EXPERIMENTAL
Intervention: Connected health devices combined with statistical process control (CUSUM) for monitoring respiratory function.
Number of subjects: 36
Study 39467550 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education associated with the intervention.
Number of subjects: 36
Study 39467591 — intervention group
Group type: EXPERIMENTAL
Intervention: PACK training (intervention)
Number of subjects: 48
Study 39467616 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual depressive symptoms
Number of subjects: 1244
Study 39467616 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline depression severity
Number of subjects: 1244
Study 39467616 — intervention group
Group type: EXPERIMENTAL
Intervention: Being in a relationship
Number of subjects: 1244
Study 39467833 — intervention group
Group type: EXPERIMENTAL
Intervention: Local skin cooling for five seconds during arteriovenous fistula cannulation
Number of subjects: 50
Study 39467833 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital protocol (control group)
Number of subjects: 50
Study 39467892 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) treatment of sockets after third molar removal
Number of subjects: 25
Study 39467892 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment of sockets after third molar removal
Number of subjects: 25
Study 39468229 — intervention group
Group type: COMPARATOR
Intervention: Urea cycle amino acids (ornithine, citrulline, homocitrulline, aspartate, arginine)
Number of subjects: 166
Study 39468229 — intervention group
Group type: COMPARATOR
Intervention: Lysine, histidine, and the glutamine/glutamate ratio
Number of subjects: 166
Study 39468444 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-Stroke Checklist (PSC) follow-up at 3 and 12 months post-stroke
Number of subjects: 200
Study 39468466 — intervention group
Group type: EXPERIMENTAL
Intervention: U. parvum serovar 14
Number of subjects: 5277
Study 39468466 — intervention group
Group type: EXPERIMENTAL
Intervention: U. parvum serovar 3
Number of subjects: 5277
Study 39468466 — intervention group
Group type: COMPARATOR
Intervention: U. parvum serovar 1
Number of subjects: 5277
Study 39468466 — intervention group
Group type: COMPARATOR
Intervention: U. parvum serovar 6
Number of subjects: 5277
Study 39468472 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal prevention consultation offered to future fathers
Number of subjects: 2516
Study 39468472 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal prevention consultation
Number of subjects: 2516
Study 39468538 — intervention group
Group type: EXPERIMENTAL
Intervention: Osseodensification sinus lift using sticky bone as a graft material
Number of subjects: 16
Study 39468538 — intervention group
Group type: COMPARATOR
Intervention: Piezoelectric internal sinus elevation (PISE) using sticky bone as a graft material
Number of subjects: 16
Study 39468582 — intervention group
Group type: EXPERIMENTAL
Intervention: Trach Plus
Number of subjects: 6
Study 39468582 — intervention group
Group type: COMPARATOR
Intervention: Trach Me Home (Comparator)
Number of subjects: 6
Study 39468592 — intervention group
Group type: EXPERIMENTAL
Intervention: Ravulizumab treatment
Number of subjects: 56
Study 39468623 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional hip abductor strength training combined with traditional physical therapy
Number of subjects: 40
Study 39468623 — intervention group
Group type: COMPARATOR
Intervention: Traditional physical therapy
Number of subjects: 40
Study 39468632 — intervention group
Group type: EXPERIMENTAL
Intervention: Cast immobilization
Number of subjects: 0
Study 39468632 — intervention group
Group type: COMPARATOR
Intervention: Operative treatment followed by cast immobilization
Number of subjects: 0
Study 39468643 — intervention group
Group type: EXPERIMENTAL
Intervention: Green coffee (GC) capsules (800 mg) daily for 6 months
Number of subjects: 160
Study 39468649 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal, digitally enhanced intervention including a smartwatch, study app, mobile integrated health program, and virtual pulmonary support service.
Number of subjects: 100
Study 39468701 — intervention group
Group type: EXPERIMENTAL
Intervention: Tucidinostat plus pediatric-inspired chemotherapy
Number of subjects: 54
Study 39468861 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium-weakness group
Number of subjects: 247
Study 39468861 — intervention group
Group type: COMPARATOR
Intervention: Delirium-only group
Number of subjects: 247
Study 39468861 — intervention group
Group type: COMPARATOR
Intervention: Weakness-only group
Number of subjects: 247
Study 39468861 — intervention group
Group type: COMPARATOR
Intervention: Normal group
Number of subjects: 247
Study 39469237 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with endometriosis
Number of subjects: 381
Study 39469237 — intervention group
Group type: COMPARATOR
Intervention: Control women
Number of subjects: 381
Study 39469237 — intervention group
Group type: EXPERIMENTAL
Intervention: Partners of women with endometriosis
Number of subjects: 381
Study 39469237 — intervention group
Group type: COMPARATOR
Intervention: Partners of control women
Number of subjects: 381
Study 39469237 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain, dyspareunia, dissatisfaction with sexuality, fatigue, and infertility
Number of subjects: 381
Study 39469237 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue and infertility
Number of subjects: 381
Study 39469237 — intervention group
Group type: EXPERIMENTAL
Intervention: Male partners in both groups
Number of subjects: 381
Study 39469237 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity of pain experienced by partner
Number of subjects: 381
Study 39469294 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtually delivered mind-body program integrating tai chi, qigong, and meditation (VDTQM), 12-week program, live online 60-minute classes twice weekly.
Number of subjects: 350
Study 39469294 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group, n=175.
Number of subjects: 350
Study 39469536 — intervention group
Group type: EXPERIMENTAL
Intervention: CVN424 50 mg
Number of subjects: 141
Study 39469536 — intervention group
Group type: EXPERIMENTAL
Intervention: CVN424 150 mg
Number of subjects: 141
Study 39469536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 39469537 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary inorganic nitrate (70 mL of nitrate-containing beetroot juice) for 6 months
Number of subjects: 300
Study 39469537 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nitrate-deplete juice) for 6 months
Number of subjects: 300
Study 39469641 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple combination of vemurafenib (vem), cobimetinib (cobi), and atezolizumab (atezo)
Number of subjects: 59
Study 39469838 — intervention group
Group type: EXPERIMENTAL
Intervention: Dato-DXd + pembrolizumab + platinum-based chemotherapy
Number of subjects: 0
Study 39469838 — intervention group
Group type: EXPERIMENTAL
Intervention: Dato-DXd + pembrolizumab
Number of subjects: 0
Study 39469838 — intervention group
Group type: COMPARATOR
Intervention: pembrolizumab + pemetrexed + platinum chemotherapy
Number of subjects: 0
Study 39470043 — intervention group
Group type: EXPERIMENTAL
Intervention: 0h/1h hs-cTnT protocol
Number of subjects: 26040
Study 39470043 — intervention group
Group type: COMPARATOR
Intervention: 0h/3h hs-cTnT protocol
Number of subjects: 26040
Study 39470045 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS) performed during the first 24 hours after angiography
Number of subjects: 373
Study 39470045 — intervention group
Group type: EXPERIMENTAL
Intervention: LUS score as an independent predictor
Number of subjects: 373
Study 39470045 — intervention group
Group type: EXPERIMENTAL
Intervention: Detecting B-lines on LUS
Number of subjects: 373
Study 39470058 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 668
Study 39470180 — intervention group
Group type: EXPERIMENTAL
Intervention: YBCS's perceived cancer risk
Number of subjects: 310
Study 39470180 — intervention group
Group type: EXPERIMENTAL
Intervention: Older relatives' physical QOL at baseline
Number of subjects: 310
Study 39470180 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic, clinical, and psychosocial factors (age, race, marital status, years since diagnosis, education, out-of-pocket costs of care, routine sources of care, income, family support, fear of recurrence, anxiety, and depression)
Number of subjects: 310
Study 39470206 — intervention group
Group type: COMPARATOR
Intervention: Conservative interventions (assessment-based nursing, holistic nursing, probiotics, psyllium, faecal microbiota transplantation, stepwise protocol of increasingly invasive evacuation methods)
Number of subjects: 1598
Study 39470206 — intervention group
Group type: COMPARATOR
Intervention: Conservative interventions
Number of subjects: 1598
Study 39470206 — intervention group
Group type: COMPARATOR
Intervention: Physical therapies (massage therapy, standing, osteopathic manipulative treatment, electrical stimulation, transanal irrigation, conventional physical therapy with visceral mobilisation)
Number of subjects: 1598
Study 39470206 — intervention group
Group type: COMPARATOR
Intervention: Physical therapies
Number of subjects: 1598
Study 39470206 — intervention group
Group type: COMPARATOR
Intervention: Surgical interventions
Number of subjects: 1598
Study 39470284 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care nucleic acid device using caregiver/patient self-collected buccal swabs
Number of subjects: 2640
Study 39470284 — intervention group
Group type: COMPARATOR
Intervention: Reference standard: nasopharyngeal swab specimens collected by a healthcare provider tested via laboratory RT-PCR
Number of subjects: 2640
Study 39470337 — intervention group
Group type: EXPERIMENTAL
Intervention: Right Bundle Branch Block (RBBB)
Number of subjects: 248
Study 39470337 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Bundle Branch Block (LBBB)
Number of subjects: 248
Study 39470337 — intervention group
Group type: EXPERIMENTAL
Intervention: No Bundle Branch Block (No BBB)
Number of subjects: 248
Study 39470337 — intervention group
Group type: EXPERIMENTAL
Intervention: RBBB
Number of subjects: 248
Study 39470337 — intervention group
Group type: EXPERIMENTAL
Intervention: LBBB
Number of subjects: 248
Study 39470337 — intervention group
Group type: EXPERIMENTAL
Intervention: No BBB
Number of subjects: 248
Study 39470337 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate
Number of subjects: 248
Study 39470337 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin I
Number of subjects: 248
Study 39470337 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute Physiology Score
Number of subjects: 248
Study 39470416 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragmatic motion assessment in patients with pneumonia
Number of subjects: 39
Study 39470416 — intervention group
Group type: COMPARATOR
Intervention: Diaphragmatic motion assessment in patients with exacerbation of chronic obstructive pulmonary disease
Number of subjects: 39
Study 39470416 — intervention group
Group type: COMPARATOR
Intervention: Diaphragmatic motion assessment in patients with acute heart failure
Number of subjects: 39
Study 39470511 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 90
Study 39470511 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadratus Lumborum Block (QLB)
Number of subjects: 90
Study 39470511 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 39470554 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) + medical treatment + stabilization splint
Number of subjects: 61
Study 39470554 — intervention group
Group type: COMPARATOR
Intervention: Control group (medical treatment + stabilization splint)
Number of subjects: 61
Study 39470695 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital care program (DCP) with race/ethnicity concordance
Number of subjects: 71201
Study 39470695 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital care program (DCP) with gender concordance
Number of subjects: 71201
Study 39470705 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth PA intervention (n=50)
Number of subjects: 99
Study 39470705 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=49)
Number of subjects: 99
Study 39470716 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy Hands app-based self-management intervention
Number of subjects: 71
Study 39470752 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial strain measurement
Number of subjects: 0
Study 39470752 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic stiffness measurement
Number of subjects: 0
Study 39470752 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand grip strength assessment
Number of subjects: 0
Study 39470752 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee extensor strength assessment
Number of subjects: 0
Study 39470752 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle oxygenation recording
Number of subjects: 0
Study 39470752 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise test
Number of subjects: 0
Study 39470752 — intervention group
Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 0
Study 39470786 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium-166 radioembolisation
Number of subjects: 31
Study 39470788 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behaviour Therapy for adolescents (DBT-A)
Number of subjects: 77
Study 39470788 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 77
Study 39470788 — intervention group
Group type: EXPERIMENTAL
Intervention: DBT-A
Number of subjects: 77
Study 39470875 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ablative diode laser therapy
Number of subjects: 22
Study 39470878 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 0
Study 39470878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 39470977 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted recruitment strategies (including revised language and imagery, targeted outreach, and incorporation of treating physicians) implemented post-May 17, 2022.
Number of subjects: 385
Study 39470977 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted recruitment strategies
Number of subjects: 385
Study 39470977 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in recruitment letter
Number of subjects: 385
Study 39471078 — intervention group
Group type: EXPERIMENTAL
Intervention: CART identified lower IL9, lower presentation pulse rate, and higher eotaxin as predictors of vasospasm development.
Number of subjects: 53
Study 39471078 — intervention group
Group type: EXPERIMENTAL
Intervention: LASSO identified higher Rotterdam computed tomography score and lower age as risk factors for vasospasm development.
Number of subjects: 53
Study 39471078 — intervention group
Group type: EXPERIMENTAL
Intervention: CART identified high levels of eotaxin as most predictive of mortality.
Number of subjects: 53
Study 39471078 — intervention group
Group type: EXPERIMENTAL
Intervention: LASSO identified higher serum IL6, lower IL12, and higher glucose as predictive of mortality.
Number of subjects: 53
Study 39471088 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuro-Spinal Scaffold (NSS) implantation
Number of subjects: 20
Study 39471088 — intervention group
Group type: COMPARATOR
Intervention: Spine surgery alone (control group)
Number of subjects: 20
Study 39471309 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR with Sentinel cerebral embolic protection (CEP) device
Number of subjects: 3000
Study 39471309 — intervention group
Group type: COMPARATOR
Intervention: TAVR alone
Number of subjects: 3000
Study 39471424 — intervention group
Group type: EXPERIMENTAL
Intervention: Selpercatinib 20 mg QD or 20-240 mg BID in phase I; 160 mg BID in phase II.
Number of subjects: 837
Study 39471473 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Exchange (WE)
Number of subjects: 386
Study 39471473 — intervention group
Group type: COMPARATOR
Intervention: CO2 Insufflation (Control)
Number of subjects: 386
Study 39471475 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord blood transplantation (UCBT) with standard-of-care myeloablative conditioning; 4 subjects also received intrathecal DUOC-01 cells posttransplant.
Number of subjects: 8
Study 39471820 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIC) twice daily for 2-4 days before carotid artery stenting (CAS) as an adjunct to standard medical therapy
Number of subjects: 0
Study 39471820 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 39471820 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIC)
Number of subjects: 0
Study 39472058 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone replacement (20 mg/day for 3 months, then 10 mg/day for 3 months)
Number of subjects: 102
Study 39472058 — intervention group
Group type: COMPARATOR
Intervention: Prednisone tapering (1 mg/day every month until complete discontinuation)
Number of subjects: 102
Study 39472058 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone replacement
Number of subjects: 102
Study 39472058 — intervention group
Group type: COMPARATOR
Intervention: Prednisone tapering
Number of subjects: 102
Study 39472058 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 102
Study 39472200 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended pelvic lymph node dissection (PLND) including external iliac, obturator, and hypogastric nodes
Number of subjects: 1432
Study 39472200 — intervention group
Group type: COMPARATOR
Intervention: Limited pelvic lymph node dissection (PLND) including external iliac nodes
Number of subjects: 1432
Study 39472354 — intervention group
Group type: EXPERIMENTAL
Intervention: uPAR-PET tracer administration (approximately 200 MBq, range: 83-222 MBq)
Number of subjects: 24
Study 39472354 — intervention group
Group type: EXPERIMENTAL
Intervention: uPAR expression as a continuous variable
Number of subjects: 24
Study 39472409 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated Tobacco Products (HTPs) inhalation
Number of subjects: 23
Study 39472511 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine infusion of autologous platelet-rich plasma (PRP) 0.8-1 ml 48 hours before blastocyst ET in fresh and frozen cycles
Number of subjects: 80